2020-05354. Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at http://www.reginfo.gov/​public/​do/​PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.

    Table 1—List of Information Collections Approved By OMB

    Title of collectionOMB Control No.Date approval expires
    Obtaining Information to Understand Challenges and Opportunities Encountered by Compounding Outsourcing Facilities0910-08831/31/2021
    Protection of Human Subjects; Informed Consent; and Institutional Boards0910-01301/31/2023
    Biological Products: Reporting and Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Deviations in Manufacturing0910-04581/31/2023
    Reporting Associated with Designated New Animal Drugs for Minor Use and Minor Species0910-06051/31/2023
    Evaluation of the Food and Drug Administration's General Market Youth Tobacco Prevention Campaign0910-07531/31/2023
    Collection of Conflict of Interest Information for Participation in Food and Drug Administration Non-Employee Fellowship and Traineeship Programs0910-08821/31/2023
    Human Tissue Intended for Transplantation0910-03022/28/2023
    General Licensing Provisions: Biologics License Application, Changes to an Approved Application, Labeling, Revocation and Suspension, Postmarketing Studies Status Reports, and Form FDA 356h0910-03382/28/2023
    Procedures for the Safe Processing and Importing of Fish and Fishery Products0910-03542/28/2023
    Medical Devices; Shortages Data Collection System0910-04912/28/2023
    Focus Groups About Drug Products as Used by the Food and Drug Administration0910-06772/28/2023
    Start Printed Page 15188
    Unique Device Identification System0910-07202/28/2023
    Animal Feed Regulatory Program Standards0910-07602/28/2023
    Start Signature

    Dated: March 11, 2020.

    Lowell J. Schiller,

    Principal Associate Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 2020-05354 Filed 3-16-20; 8:45 am]

    BILLING CODE 4164-01-P

Document Information

Published:
03/17/2020
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
2020-05354
Pages:
15187-15188 (2 pages)
Docket Numbers:
Docket Nos. FDA-2019-N-3077, FDA-2013-N-0403, FDA-2013-N-0579, FDA-2016-N-2474, FDA-2013-N-0717, FDA-2018-N-3728, FDA-2013-N-0797, FDA-2013-N-0578, FDA-2013-N-0879, FDA-2012-N-0197, FDA-2016-N-3586, FDA-2016-N-4319, and FDA-2013-N-0764
PDF File:
2020-05354.Pdf